Drug approval process for ovarian cancer: Prof Maria Paolo Costi – University of Modena, Italy

Update: 2012-11-19

Description

Prof Maria Paolo Costi talks to ecancer at the 4th EUTROC meeting in Liverpool, UK about new drug developments and the main issues surrounding the drug approval process for ovarian cancer.

Prof Costi highlights work being done on folate receptors and their role in ovarian cancer; in particular, a project discussed at the meeting on candidate drugs targeting this receptor and the difficulty of advancing these drugs to the clinical stages.

Comments

In Channel

Highlights from the 4th EUTROC meeting: Prof John Green – University of Liverpool, UK

2012-11-1909:46

Development of clinical trials and bio banks: Prof Hani Gabra – Imperial College London, UK

2012-11-1904:48

Drug approval process for ovarian cancer: Prof Maria Paolo Costi – University of Modena, Italy

2012-11-1908:49

Biology of molecular sub types in ovarian cancer: Prof David Bowtell – Peter MacCallum Cancer Centre, Melbourne, Australia

2012-11-1908:30

Interplay between pathologies of ovarian cancer and genomics: Prof David Huntsman – University of British Columbia, Canada

2012-11-1904:52

Histological and molecular sub types of ovarian cancer: Dr Jozien Helleman – Erasmus Medical Centre, Rotterdam, Netherlands

2012-11-1903:54

Interaction between tumour biology and surgery: Dr Christina Fotopoulou – Charite University Hospital, Berlin, Germany

2012-11-1906:03

Early stage biomarkers in ovarian cancer: Prof Angelo Paradiso – National Cancer Research Institute, Bari, Italy

2012-11-1904:36

Sub-typing ovarian cancer: Dr Charles Gourley – University of Edinburgh Cancer Research Center, UK

2012-11-1908:49

The Merseyside and Cheshire cancer network: Dr John Kirwan – Liverpool Womens Hospital, UK

2012-11-1902:52

00:00

Drug approval process for ovarian cancer: Prof Maria Paolo Costi – University of Modena, Italy

#box-pro-ellipsis-17604713932209{-webkit-line-clamp:2;}Drug approval process for ovarian cancer: Prof Maria Paolo Costi – University of Modena, Italy

Drug approval process for ovarian cancer: Prof Maria Paolo Costi – University of Modena, Italy

ecancer.org

Drug approval process for ovarian cancer: Prof Maria Paolo Costi – University of Modena, Italy